| The success rates in community-acquired pneumonia treated consistently or inconsistently with the Turkish Thoracic Society Pneumonia Guidelines | Zeynep ORHAN, Süleyman S. HACIEVLİYAGİL, Zeki YILDIRIM, Nurhan KÖKSAL, Münire GÖKIRMAK, H. Canan HASANOĞLU | 297–311 |
| Etiology and prognosis factors in severe community-acquired pneumonia | Candan ÖĞÜŞ, Tülay ÖZDEMİR, Ayla KARA, Aykut ÇİLLİ | 312–316 |
| Identification of Mycobacterium with nucleic acid multiplication and biochemical methods on Lowenstein culture positive patients diagnosed active pulmonary tuberculosis | Aydan ÇAKAN, A. Emin ERBAYCU, M. Şevket DERELİ, Oya ERBAYCU, Zühre BADAK, Ayşe ÖZSÖZ | 321–326 |
| Semiquantitative analysis of the distribution of pulmonary ventilation and perfusion function in chronic obstructive pulmonary disease | Aydan ÇAKAN, Hayal ÖZKILIÇ, Şevket DERELİ, Ayla TEKİN, Günal ERENEL, Ayşe ÖZSÖZ | 327–332 |
| Kronik obstrüktif akciğer hastalığında yaşam kalitesi ve solunum fonksiyon testi ile ilişkisi | Bahar KURT, Serkan AKBAY, Arzu ERTÜRK, Meral GÜLHAN, Nermin ÇAPAN | 338–344 |
| Results of pulmonary function tests at school children in Diyarbakır | Orhan DERMAN, Fuat GÜRKAN, Ahmet YARAMIŞ, Erkan YURDUSEVEN, Kenan HASPOLAT, Abdurrahman ŞENYİĞİT, Ahmet KAYA | 345–353 |
| Right heart catheterization in pulmonary hypertension | İsmail YÜKSEKOL, Yücel TAŞAN, Ramazan KÖYLÜ, Metin ÖZKAN, Hayati BİLGİÇ | 354–358 |
| The evaluation of radiological findings, pulmonary function tests, electrocardiographic findings and arterial blood gases in pneumoconiosis cases | Meral SAYGUN, Arslan TUNÇBİLEK, Gülseren KARABIYIKOĞLU | 359–372 |
| Analysis of 23 cases of sarcoidosis misdiagnosed as tuberculosis | Dilek YILMAZBAYHAN, Mustafa ERELEL, Levent TABAK, Esen KIYAN, Çağlar ÇUHADAROĞLU, Orhan ARSEVEN, Zeki KILIÇASLAN | 373–379 |
| Comparative analysis of some biochemical parameters in differentiating transudates from exudates | Kunter PERİM, Emel ÇELİKTEN, Berna KÖMÜRCÜOĞLU, Melih BÜYÜKŞİRİN, Dilek KALENCİ | 380–385 |
| Mitomycin, ifosfamide and cisplatin in nonsmall cell lung cancer |